Home » Topics » Musculoskeletal, BioWorld Science

Musculoskeletal, BioWorld Science
RSS

Amgen receives positive opinion for biosimilar adalimumab ABP-501

Jan. 30, 2017

EMA committee gives positive opinion for Pfizer's Xeljanz

Jan. 30, 2017

GlaxoSmithKline studies GSK-3117391 for rheumatoid arthritis in phase II trial

Jan. 27, 2017

Mitsubishi Tanabe Pharma discovers MMP-9 production inhibitors

Jan. 25, 2017

WuXi-MedImmune cleared to conduct phase I studies of WBP-216 in China

Jan. 19, 2017

FDA, EMA accept Boehringer Ingelheim's BI-695501 for review

Jan. 19, 2017

Orion presents novel bromodomain-containing protein 4 inhibitors

Jan. 18, 2017

EC grants new orphan drug designation to Corbus' JBT-101

Jan. 18, 2017

Dendright extends collaboration with Janssen and adds Arthritis Queensland as a partner

Jan. 17, 2017

FDA extends NDA review period for baricitinib

Jan. 16, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 15, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Rethinking anorexia: A disorder of mind and metabolism
BioWorld Science
Anorexia nervosa (AN) is a complex and severe eating disorder that has long been considered a psychiatric condition driven by distorted body image and maladaptive...